IPO
Integris Medtech IPO 2026: GMP, Price Band, Review and Allotment
Integris Medtech IPO 2026: price band and lot size TBA, bidding opens 27 Nov, listing 4 Dec 2026. Check GMP status, risks, allotment steps and key review points.
WealthDox Editorial · Published 20/11/2026 · 10 min read · Updated 20/11/2026
Integris Medtech IPO Quick Facts: Dates, Price Band and Lot Size
- Price band
- To be announced
- Lot size
- TBA shares
- Opens
- 27 Nov 2026
- Closes
- 1 Dec 2026
- Listing
- 4 Dec 2026
- Issue size
- TBA
Integris Medtech has announced an IPO that will be listed on both BSE and NSE. The bidding window runs from 27 November 2026 to 1 December 2026, with listing scheduled for 4 December 2026.
The price band, lot size and total issue size have not been announced yet. Grey market premium data is also not available at this stage, so investors should treat any early numbers with caution.
Good to know
Dates can change. Always confirm the final schedule, price band and lot size from the official offer documents before you place any bid.
This article is a research checklist. It explains what to review, how the application process works and which risks to think about before deciding whether to apply.
About Integris Medtech: Business Model and Key Points
Integris Medtech is a company listing through an initial public offering on the Indian stock exchanges. Its name and the IPO timing suggest it operates in the medical technology space, but investors should confirm the exact products and services in the Red Herring Prospectus (RHP).